Content created by
Anti-Nuclear Antibody (ANA) by IFA - End Point Titer near me in New Delhi
Also known as ANA Screening, Autoimmune
You need to provide
Blood
This test is for
Male, Female
Test Preparation
Understanding Anti-Nuclear Antibody (ANA) by IFA - End Point Titer in New Delhi
What is Anti-Nuclear Antibody (ANA) by IFA - End Point Titer in New Delhi?
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer, a blood test available at an affordable price with Tata 1mg labs in New Delhi is used to detect the presence of antinuclear antibodies (ANAs) or autoantibodies that target the nuclei of cells in the body. These antibodies can mistakenly attack the body's own tissues, leading to autoimmune diseases such as lupus, rheumatoid arthritis, or Sjogren’s syndrome.
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is typically suggested when a doctor suspects an autoimmune disorder due to symptoms such as joint pain, fatigue, skin rashes, light sensitivity, or inflammation. Also, it may be advised if there are risk factors such as aging, obesity, and a family history of autoimmune diseases. No special preparation is required for this test.
What does Anti-Nuclear Antibody (ANA) by IFA - End Point Titer measure?
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test checks for antinuclear antibodies (ANA) in your blood. These antibodies, different from typical ones that fight off invaders in the body, can attach to structures inside the body’s own cell nuclei. If ANAs are present in the blood, it may suggest that your immune system is overly sensitive, causing inflammation against your own tissues and possibly indicating autoimmune diseases.
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Anti-Nuclear Antibody (ANA) by IFA - End Point Titer in New Delhi
Frequently Asked Questions about Anti-Nuclear Antibody (ANA) by IFA - End Point Titer in New Delhi
Q. What is an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test?
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is a blood test that detects antibodies targeting the cell nucleus. It helps diagnose autoimmune diseases where the immune system mistakenly attacks the body's own cells.
Q. Why is an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test done?
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is done to identify autoimmune disorders, especially when individuals exhibit symptoms like joint pain, fatigue, or skin rashes. It aids in early detection and guides appropriate treatment.
Q. How is an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test performed?
A blood sample is taken from a vein, usually in the arm. The sample is then analyzed in a laboratory to measure the presence and concentration of antinuclear antibodies.
Q. How often should I get an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test done?
The frequency of ANA testing depends on individual health conditions and recommendations by your doctor.
Q. Is there any risk associated with an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test?
No, there is no risk associated with an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test. However, some individuals may feel a slight sting when a needle is pricked and experience some bleeding that is normal and usually not bothersome. Rarely, some individuals may also experience slight swelling or bruising at the site of the needle prick. Applying ice 3-4 times a day for about a week may help reduce swelling and bruising. If it does not get better, consult your doctor.
Q. Does Tata 1mg Labs offer an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test in New Delhi near me?
Yes, Tata 1mg Labs offers an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test in New Delhi near you. The test is easy to book, is pocket-friendly, and comes with a comprehensible report.
Q. Is home sample collection facility available for an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test in New Delhi with Tata 1mg Labs?
Yes, home sample collection for an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is readily available in New Delhi. Tata 1mg Labs allows you to choose a date and time that suits your schedule for sample collection.
Q. How can I schedule an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test with Tata 1mg Labs in New Delhi?
If you want to schedule an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test with Tata 1mg Labs in New Delhi, the procedure is fairly easy and hassle-free. Follow these steps to book a test: 1). Visit the Lab Tests section on the Tata 1mg website. 2). Add the test you want in the cart. 3). Pick a time and date slot according to your convenience; however, do consider the necessary prerequisites while scheduling a test. 4). You will receive a notification with all the details once the test is scheduled.
Q. What is the cost of an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test at Tata 1mg Labs in New Delhi?
Tata 1mg Labs is a pocket-friendly platform for booking lab tests in New Delhi. An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is available at an affordable price of Rs. 1309.
Q. How long does Tata 1mg Labs take to give the reports of an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test in New Delhi?
At Tata 1mg Labs, we understand the importance of timely results. We strive to provide fast turnaround times for test results, allowing you to get the information you need promptly. On average, we take 48 hours to provide the reports of an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test in New Delhi.
+ more
Book a Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test at home near me
Easy online booking
Search for tests and packages, book a time and select address for seamless at-home lab tests.
Live tracking of phlebotomist
Stay informed with live tracking of our phlebotomist's location for seamless sample collection.
Safe collection
Our phlebotomists follow strict safety protocols to collect samples at home on time.
Sample received at lab
Your sample is bought to our laboratory for testing by our qualified experts.
Quick reports, free follow up
Reports are sent to your email. A free doctor follow up is provided to understand the report better.
References
- Antinuclear Antibody [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 22 Dec. 2023]. Available from: https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=167&contentid=antinuclear_antibodies
- Rheumatoid Factor - an overview [Internet]. ScienceDirect; [Accessed 22 Dec. 2023]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/rheumatoid-factor
- Overview of Systemic Lupus Erythematosus (Lupus) [Internet]. NIH; Oct. 2022. [Accessed 22 Dec. 2023]. Available from: https://www.niams.nih.gov/health-topics/lupus
- Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol. 2009 Jan 2;4:1. [Accessed 22 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628865/
- Nosal RS, Superville SS, Amraei R, et al. Biochemistry, Antinuclear Antibodies (ANA) [Updated 2022 Dec 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537071/
- Tešija Kuna A, Đerek L, Drvar V, Kozmar A, Gugo K. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Med (Zagreb). 2022 Jun 15;31(2):020502. [Accessed 22 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047791/
- Grygiel-Górniak B, Rogacka N, Puszczewicz M. Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications. Reumatologia. 2018;56(4):243-248. [Accessed 22 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142026/
- Li QZ, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, Chong BF, Wakeland EK, Olsen NJ. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011 Mar 2;13(2):R38. [Accessed 22 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132017/
- Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011 Oct;6(4):330-6. PMID: 22879850; PMCID: PMC3391953. [Accessed 22 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391953/
Other tests
Popular tests in New Delhi
Other similar tests in New Delhi
Our popular tests
Provided by 1 Lab
Frequently Booked Together